Rapid skull growth marker and application thereof
By detecting the expression levels of FAK, Twist1, and related bone growth factors, the problem of inaccurate timing of pediatric cranial defect repair surgery was solved, enabling precise cranial repair and postoperative management, and improving the success rate and safety of the surgery.
Patent Information
- Application Number
- CN202511927717.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-19
- Publication Date
- 2026-04-14
AI Technical Summary
Current technologies lack key biomarkers based on the pressure/dura mater FAK-Twist1 pathway, leading to inaccurate timing of pediatric skull defect repair surgery, which may affect skull growth and development and increase the risk of complications.
FAK, Twist1, and related soluble bone growth factors (such as BMP-2 and TGF-β1) were used as markers of rapid skull growth. By detecting their mRNA and protein expression levels, the growth and development status of the skull was assessed, guiding the appropriate timing of repair and postoperative monitoring.
It has improved the success rate and safety of cranial defect repair surgery, reduced complications, provided personalized treatment plans and postoperative prognostic assessments, and reduced reliance on imaging equipment and physician experience.